{
  "id": "clinical#screening_cues_5479a883",
  "content": "Anxiety and depressive disorders. Discontinuation symptoms of-\nten resemble symptoms of a persistent anxiety disorder or a return of\nsomatic symptoms of depression for which the medication was ini-\ntially given.\nMedication-Induced Movement Disorders 353\nSubstance use disorders. Antidepressant discontinuation syn-\ndrome differs from substance withdrawal in that antidepressants\nthemselves have no reinforcing or euphoric effects. The medication\ndosage has usually not been increased without the clinician’s permis-\nsion, and the individual generally does not engage in drug-seeking\nbehavior to obtain additional medication. Criteria for a substance\nuse disorder are not met.\nTolerance to medications. Tolerance and discontinuation symp-\ntoms can occur as a normal physiological response to stopping med-\nication after a substantial duration of exposure. Most cases of\nmedication tolerance can be managed through carefully controlled\ntapering.\nComorbidity\nTypically, the individual was initially started on the medication for\na major depressive disorder; the original symptoms may return dur-\ning the discontinuation syndrome.\nOther Adverse Effect of Medication\n995.20 (T50.905A) Initial encounter\n995.20 (T50.905D) Subsequent encounter\n995.20 (T50.905S) Sequelae\nThis category is available for optional use by clinicians to code side\neffects of medication (other than movement symptoms) when these",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues Anxiety and depressive disorders. Discontinuation symptoms of-\nten resemble symptoms of a persistent anxiety disorder or a return of\nsomatic symptoms of depression for which the medication was ini-\ntially given.\nMedication-Induced Movement Disorders 353\nSubstance use disorders. Antidepressant discontinuation syn-\ndrome differs from substance withdrawal in that antidepressants\nthemselves have no reinforcing or euphoric effects. The medication\ndosage has usually not been increased without the clinician’s permis-\nsion, and the individual generally does not engage in drug-seeking\nbehavior to obtain additional medication. Criteria for a substance\nuse disorder are not met.\nTolerance to medications. Tolerance and discontinuation symp-\ntoms can occur as a normal physiological response to stopping med-\nication after a substantial duration of exposure. Most cases of\nmedication tolerance can be managed through carefully controlled\ntapering.\nComorbidity\nTypically, the individual was initially started on the medication for\na major depressive disorder; the original symptoms may return dur-\ning the discontinuation syndrome.\nOther Adverse Effect of Medication\n995.20 (T50.905A) Initial encounter\n995.20 (T50.905D) Subsequent encounter\n995.20 (T50.905S) Sequelae\nThis category is available for optional use by clinicians to code side\neffects of medication (other than movement symptoms) when these Lo âu and depressive disorders. discontinuation symptoms of-\nten resemble symptoms of a persistent lo âu disorder or a return of\nsomatic symptoms of trầm cảm for which the medication was ini-\ntially given."
}